The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD

References

• Global initiative for chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD. Bethesda, MD: GOLD; 2011.
   Google Scholar
• Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397–412. doi: 10.1183/09031936.06.00025805
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology 2004;9:458–65. doi: 10.1111/j.1440-1843.2004.00637.x
   PubMed Web of Science ®Google Scholar
• Fukahori S, Matsuse H, Takamura N, Hirose H, Tsuchida T, Kawano T, et al. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC. Int J Clin Pract 2009;63:269–74. doi: 10.1111/j.1742-1241.2008.01873.x
   PubMed Web of Science ®Google Scholar
• Kitchener RL, Grunden AM. Prolidase function in proline metabolism and its medical and biotechnological applications. J Appl Microbiol 2012;113:233–47. doi: 10.1111/j.1365-2672.2012.05310.x
   PubMed Web of Science ®Google Scholar
• Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica 1994;79:13–8.
   PubMed Web of Science ®Google Scholar
• Rabus M, Demirbag R, Yildiz A, Tezcan O, Yilmaz R, Ocak AR, et al. Association of prolidase activity, oxidative parameters, and presence of atrial fibrillation inpatients with mitral stenosis. Arch Med Res 2008;39:519–24. doi: 10.1016/j.arcmed.2008.03.002
   PubMed Web of Science ®Google Scholar
• Camuzoglu H, Arioz DT, Toy H, Kurt S, Celik H, Aksoy N. Assessment of preoperative serum prolidase activity in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2009;147:97–100. doi: 10.1016/j.ejogrb.2009.07.012
   PubMed Web of Science ®Google Scholar
• Cakmak A, Zeyrek D, Atas A, Celik H, Aksoy N, Erel O. Serum prolidase activity and oxidative status in patients with bronchial asthma. J Clin Lab Anal 2009;23(2):132–8. doi: 10.1002/jcla.20303
   PubMed Web of Science ®Google Scholar
• Gencer M, Aksoy N, Dagli EC, Uzer E, Aksoy S, Selek S, et al. Prolidase activity dysregulation and its correlation with oxidative–antioxidative status in chronic obstructive pulmonary disease. J Clin Lab Anal 2011;25: 8–13. doi: 10.1002/jcla.20347
   PubMed Web of Science ®Google Scholar
• Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399–406. doi: 10.1161/01.CIR.74.6.1399
   PubMed Web of Science ®Google Scholar
• Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999;30:841–50. doi: 10.1161/01.STR.30.4.841
   PubMed Web of Science ®Google Scholar
• Ozcan O, Gultepe M, Ipcioglu OM, Bolat B, Kayadibi H. Optimization of the photometric enzyme activity assay for evaluating real activity of prolidase. Turk J Biochem 2007;32:12–6.
   Web of Science ®Google Scholar
• Myara I, Cosson C, Moatti N, Lemonnier A. Human kidney prolidase – purification, preincubation properties and immunological reactivity. Int J Biochem 1994;26:207–14. doi: 10.1016/0020-711X(94)90147-3
   PubMedGoogle Scholar
• Erbagci AB, Araz M, Erbagci A, Tarakçioğlu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Chem 2002;35:263–268.
   Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–11. doi: 10.1016/j.clinbiochem.2005.08.008
   PubMed Web of Science ®Google Scholar
• Aycicek A, Erel O, Kocyigit A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 2005;47:635–9. doi: 10.1111/j.1442-200x.2005.02137.x
   PubMed Web of Science ®Google Scholar
• Ceylan E, Aksoy N, Gencer M, Vural H, Keles H, Selek S. Evaluation of oxidative–antioxidative status and the l-arginine–nitric oxide pathway in asthmatic patients. Respir Med 2005;99:871–6. doi: 10.1016/j.rmed.2004.12.001
   PubMed Web of Science ®Google Scholar
• Aksoy N, Vural H, Sabuncu T, Aksoy S. Effects of melatonin on oxidative–antioxidative status of tissues in streptozotocin-induced diabetic rats. Cell Biochem Funct 2003;21:121–5. doi: 10.1002/cbf.1006
   PubMed Web of Science ®Google Scholar
• Verma AK, Chandra S, Singh RG, Singh TB, Srivastava S, Srivastava R. Serum prolidase activity and oxidative stress in diabetic nephropathy and end stage renal disease: a correlative study with glucose and creatinine. Biochem Res Int 2014;2014:291458.
   PubMedGoogle Scholar
• Duygu F, Koruk ST, Karsen H, Aksoy N, Taskin A, Hamidanoglu M. Prolidase and oxidative stress in chronic hepatitis C. J Clin Lab Anal 2012;26:232–7. doi: 10.1002/jcla.21510
   PubMed Web of Science ®Google Scholar
• Şen V, Uluca Ü, Ece A, Kaplan İ, Bozkurt F, Aktar F, et al. Serum prolidase activity and oxidant–antioxidant status in children with chronic hepatitis B virüs infection. Ital J Pediatr 2014;40:95. doi: 10.1186/s13052-014-0095-1
   PubMed Web of Science ®Google Scholar
• Uzar E, Tamam Y, Evliyaoglu O, Tuzcu A, Beyaz C, Acar A, et al. Serum prolidase activity and oxidative status in patients with diabetic neuropathy. Neurol Sci 2012;33(4):875–80. doi: 10.1007/s10072-011-0857-0
   PubMed Web of Science ®Google Scholar
• Sayın R, Aslan M, Kucukoglu ME, Luleci A, Atmaca M, Esen R, et al. Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy. Endocrine 2014;47(1):146–51. doi: 10.1007/s12020-013-0136-3
   PubMed Web of Science ®Google Scholar